Moleculin Biotech, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Moleculin Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $427K, a 10.9% decline year-over-year.
  • Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.73M, a 13% decline year-over-year.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.73M, a 13% decline from 2023.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.98M, a 12.8% decline from 2022.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.28M, a 4.13% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.73M -$258K -13% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 $1.98M -$291K -12.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 $2.28M -$98K -4.13% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $2.37M +$693K +41.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $1.68M +$143K +9.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.54M +$397K +34.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $1.14M +$433K +61.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $707K +$383K +118% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 $324K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.